LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: Clinical, PET, and functional studies

Journal of Biomedical Science

Volumn 15, Issue 5, 2008, Pages 661-667

  Lin, Chin Hsien ^a   Tzen, Kai Yuan ^a   Yu, Chin Yi ^b   Tai, Chun Hwei ^a   Farrer, Matthew J ^c   Wu, Ruey Meei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Taipei Hospital   (Taiwan)

^c MAYO CLINIC   (United States)

Author keywords

Chinese; LRRK2; Parkinson's disease; PET; Taiwanese

Indexed keywords

DOPA; LEUCINE RICH REPEAT KINASE 2; PROTEASOME INHIBITOR; TIOXAMAST;

ADULT; AGED; APOPTOSIS; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MALE; PARKINSON DISEASE; PEDIGREE ANALYSIS; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; TAIWAN;

DIAGNOSTIC IMAGING; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; GENE FREQUENCY; HUMANS; MUTATION, MISSENSE; PARKINSON DISEASE; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TAIWAN;

EID: 51349127197     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-008-9260-0     Document Type: Article

References (34)

1. A Zimprich S Biskup P Leitner P Lichtner M Farrer S Lincoln J Kachergus M Hulihan RJ Uitti DB Calne AJ Stoessl RF Pfeiffer N Patenge IC Carbajal P Vieregge F Asmus B Müller-Myhsok DW Dickson T Meitinger TM Strom ZK Wszolek T Gasser 2004 Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology Neuron 44 601 607
2. C Paisán-Ruíz S Jain EW Evans WP Gilks J Simón M van der Brug A López de Munain S Aparicio AM Gil N Khan J Johnson JR Martinez D Nicholl IM Carrera AS Pena R de Silva A Lees JF Martí- Massó J Pérez-Tur NW Wood AB Singleton 2004 Cloning of the gene containing mutations that cause PARK8-linked Parkinson' s disease Neuron 44 595 600
3. M Funayama K Hasegawa E Ohta N Kawashima M Komiyama H Kowa S Tsuji F Obata 2005 An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family Ann Neurol 57 918 921
4. CS Lu EJ Simons YH Wu-Chou AD Fonzo HC Chang RS Chen YH Weng CF Rohé GJ Breedveld N Hattori T Gasser BA Oostra V Bonifati 2005 The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease Parkinsonism Relat Disord 11 521 522
5. EK Tan H Shen LC Tan M Farrer K Yew E Chua RD Jamora K Puvan KY Puong Y Zhao R Pavanni MC Wong Y Yih L Skipper JJ Liu 2005 The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients Neurosci Lett 384 327 329
6. H Tomiyama Y Li M Funayama K Hasegawa H Yoshino S Kubo K Sato T Hattori CS Lu R Inzelberg R Djaldetti E Melamed R Amouri N Gouider-Khouja F Hentati Y Hatano M Wang Y Imamichi K Mizoguchi H Miyajima F Obata T Toda MJ Farrer Y Mizuno N Hattori 2006 Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries Mov Disord 21 1102 1108
7. HC Fung CM Chen J Hardy D Hernandez A Singleton YR Wu 2006 Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease Mov Disord 21 880 881
8. IF Mata JM Kachergus JP Taylor S Lincoln J Aasly T Lynch MM Hulihan SA Cobb RM Wu CS Lu C Lahoz ZK Wszolek MJ Farrer 2005 Lrrk2 pathogenic substitutions in Parkinson's disease Neurogenetics 6 171 177
9. A Di Fonzo YH Wu-Chou CS Lu M van Doeselaar EJ Simons CF Rohé HC Chang RS Chen YH Weng N Vanacore GJ Breedveld BA Oostra V Bonifati 2006 A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan Neurogenetics 7 133 138
10. MJ Farrer JT Stone CH Lin JC Dächsel MM Hulihan K Haugarvoll OA Ross RM Wu 2007 Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia Parkinsonism Relat Disord 13 89 92
11. Fung HC, Chen CM, Hardy J, Singleton AB, Wu YR (2006) A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol 6:47
12. M Funayama Y Li H Tomiyama H Yoshino Y Imamichi M Yamamoto M Murata T Toda Y Mizuno N Hattori 2007 Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population Neuroreport 18 273 275
13. EK Tan Y Zhao L Skipper MG Tan A Di Fonzo L Sun S Fook-Chong S Tang E Chua Y Yuen L Tan R Pavanni MC Wong P Kolatkar CS Lu V Bonifati JJ Liu 2007 The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence Hum Genet 120 857 863
14. L Cao T Zhang Q Xiao Y Wang L Bai GQ Lu JF Ma J Zhang JQ Ding SD Chen 2007 The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease Mov Disord 15 2439 2443
15. Ana XK, Penga R, Lib T, Burgundera JM, Wua Y, Chena WJ, Zhanga JH, Wang YC, Xua YM, Gou YR, Yuan GG, Zhang ZJ (2008) LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Eur J Neurol. Jan 14 [Epub ahead of print]
16. A Di Fonzo C Tassorelli M De Mari HF Chien J Ferreira CF Rohé G Riboldazzi A Antonini G Albani A Mauro R Marconi G Abbruzzese L Lopiano E Fincati M Guidi P Marini F Stocchi M Onofrj V Toni M Tinazzi G Fabbrini P Lamberti N Vanacore G Meco P Leitner RJ Uitti ZK Wszolek T Gasser EJ Simons GJ Breedveld S Goldwurm G Pezzoli C Sampaio E Barbosa E Martignoni BA Oostra V Bonifati Italian Parkinson's Genetics Network 2006 Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease Eur J Hum Genet 14 322 331
17. Fahn S, Elton RI, Members of the UPDRS Development Committee UPsDRS (1987) Recent developments in Parkinson's Disease. In: Fahn S, Marsden CD, Goldstein M, Calne CD (eds) The unified Parkinson's disease rating scale, vol II. McMillan Healthcare Information, Florham Park, NJ, pp 153-163
18. MF Folstein SE Folstein PR McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198
19. RL Doty P Shaman M Dann 1984 Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function Physiol Behav 32 489 502
20. RM Wu DE Shan CM Sun RS Liu WL Hwu CH Tai J Hussey A West K Gwinn-Hardy J Hardy J Chen M Farrer S Lincoln 2002 Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and Parkin gene mutations Mov Disord 17 670 675
21. DJ Gelb E Oliver S Gilman 1999 Diagnostic criteria for Parkinson disease Arch Neurol 56 33 39
22. H Neitzel 1986 A routine method for the establishment of permanent growing lymphoblastoid cell lines Hum Genet 73 320 326
23. JH Qiu A Asai S Chi N Saito H Hamada T Kirino 2000 Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons J Neurosci 20 259 265
24. IF Mata JP Taylor J Kachergus M Hulihan C Huerta C Lahoz M Blazquez LM Guisasola C Salvador R Ribacoba C Martinez M Farrer V Alvarez 2005 LRRK2 R1441G in Spanish patients with Parkinson's disease Neurosci Lett 382 309 311
25. CP Zabetian A Samii AD Mosley JW Roberts BC Leis D Yearout WH Raskind A Griffith 2005 A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations Neurology 65 741 744
26. C Spanaki H Latsoudis A Plaitakis 2006 LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP Neurology 67 1518 1519
27. Y Huang GM Halliday H Vandebona GD Mellick F Mastaglia J Stevens J Kwok M Garlepp PA Silburn MK Horne K Kotschet A Venn DB Rowe JP Rubio CM Sue 2007 Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease Mov Disord 22 982 989
28. JJ Ferreira LC Guedes MM Rosa M Coelho M van Doeselaar D Schweiger A Di Fonzo BA Oostra C Sampaio V Bonifati 2007 High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal Mov Disord 22 1194 1201
29. OA Ross M Toft AJ Whittle JL Johnson S Papapetropoulos DC Mash I Litvan MF Gordon ZK Wszolek MJ Farrer DW Dickson 2006 Lrrk2 and Lewy body disease Ann Neurol 59 388 93
30. H Braak K Del Tredici U Rüb RA de Vos EN Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211
31. AB West DJ Moore S Biskup A Bugayenko WW Smith CA Ross VL Dawson TM Dawson 2005 Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity Proc Natl Acad Sci USA 102 16842 16847
32. E Greggio S Jain A Kingsbury R Bandopadhyay P Lewis A Kaganovich MP van der Brug A Beilina J Blackinton KJ Thomas R Ahmad DW Miller S Kesavapany A Singleton A Lees RJ Harvey K Harvey MR Cookson 2006 Kinase activity is required for the toxic effects of mutant LRRK2/dardarin Neurobiol Dis 23 329 341
33. EK Tan S Fook-Chong Z Yi 2007 Comparing LRRK2 Gly2385Arg carriers with noncarriers Mov Disord 22 749 750
34. Lee MJ, Mata IF, Lin CH, Tzen KY, Lincoln SJ, Bounds R, Lockhart PJ, Hulihan MM, Farrer MJ, Wu RM (2008) Genotype-phenotype correlates in Taiwanese patients with early-onset recessive parkinsonism. Mov Disord (in press)